Pradžia › Ūmi mieloidinė leukemija
Ūmi mieloidinė leukemija klinikiniai tyrimai JAV ieško dalyvių
276 tyrimai dėl Ūmi mieloidinė leukemija ieško dalyvių vietose visoje Jungtinėse Valstijose.
Miestai su daugiausia tyrimų
- Houston, TX85 tyrimai
- New York City, NY51 tyrimas
- Boston, MA44 tyrimai
- Baldwin Park, CA40 tyrimai
- Seattle, WA40 tyrimai
- Columbus, OH35 tyrimai
- Philadelphia, PA34 tyrimai
- Durham, NC33 tyrimai
- Atlanta, GA30 tyrimai
- Tampa, FL29 tyrimai
- Chicago, IL26 tyrimai
- Portland, OR25 tyrimai
- Miami, FL24 tyrimai
- Washington, DC24 tyrimai
- Los Angeles, CA24 tyrimai
- St. Louis, MO22 tyrimai
- Dallas, TX21 tyrimas
- Nashville, TN21 tyrimas
- Birmingham, AL21 tyrimas
- Queens, NY21 tyrimas
- Cincinnati, OH20 tyrimai
- Cleveland, OH20 tyrimai
- Edison, NJ20 tyrimai
- Minneapolis, MN20 tyrimai
- Buffalo, NY19 tyrimai
- Mountain View, CA19 tyrimai
- Baltimore, MD19 tyrimai
- Pittsburgh, PA18 tyrimai
- Winston-Salem, NC18 tyrimai
- Greenburgh, NY18 tyrimai
- Salt Lake City, UT17 tyrimai
- Ann Arbor, MI17 tyrimai
- New Haven, CT17 tyrimai
- Milwaukee, WI17 tyrimai
- Rochester, NY16 tyrimai
- Charlotte, NC16 tyrimai
- Aurora, CO16 tyrimai
- Cedar Rapids, IA16 tyrimai
- Charlottesville, VA16 tyrimai
- Madison, WI16 tyrimai
Pagal valstiją
- Aidahas9 tyrimai
- Ajova17 tyrimai
- Alabama21 tyrimas
- Arizona22 tyrimai
- Arkansas13 tyrimai
- Delaveras7 tyrimai
- Džordžija38 tyrimai
- Florida55 tyrimai
- Havajai7 tyrimai
- Ilinoisas31 tyrimas
- Indianas14 tyrimai
- Kalifornija79 tyrimai
- Kanzasas20 tyrimai
- Kentukis14 tyrimai
- Koloradas22 tyrimai
- Kolumbijos apskritis10 tyrimai
- Konektikutas17 tyrimai
- Luiziana13 tyrimai
- Masčusetsas45 tyrimai
- Menas9 tyrimai
- Merilendas31 tyrimas
- Minesota27 tyrimai
- Misisipė8 tyrimai
- Misūris23 tyrimai
- Mičiganas24 tyrimai
- Montana6 tyrimai
- Naujoji Hampšyras9 tyrimai
- Nebraska10 tyrimai
- Nevada9 tyrimai
- New Jersey32 tyrimai
- New Mexico9 tyrimai
- New York71 tyrimas
- North Carolina43 tyrimai
- North Dakota4 tyrimai
- Ohio57 tyrimai
- Oklahoma14 tyrimai
- Oregon27 tyrimai
- Pennsylvania45 tyrimai
- Rhode Island11 tyrimai
- South Carolina16 tyrimai
- South Dakota6 tyrimai
- Tennessee31 tyrimas
- Texas94 tyrimai
- Utah17 tyrimai
- Vermont7 tyrimai
- Virginia24 tyrimai
- Washington41 tyrimas
- West Virginia6 tyrimai
- Wisconsin25 tyrimai
Nesenai atnaujinti tyrimai
Oficialus tyrimo tekstas (anglų kalba)
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
Renkami dalyviai2/3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT07581002Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Renkami dalyviai2 fazė
Amžius 60 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT07437950Olutasidenib With Azacitidine Followed by Olutasidenib Maintenance for the Treatment of IDH1-mutated Acute Myeloid Leukemia in Patients With Prior Treatment With Venetoclax Plus a Hypomethylating Agent
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT07304011Assessment of Geriatric Evaluations Impact on New AML Guidance
Renkami dalyviaiStebimasis tyrimas
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT05909501Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Renkami dalyviai1 fazė
Amžius nuo 18 iki 120 · Visoms lytims · Atnaujinta 2026-10-02 · NCT06904066Phase 1 Open-label Study of AMX-883 Alone in Participants With AML and High-risk MDS and in Combination in Participants With AML
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT07723703Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 40 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT05334069Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT06484062Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 0 iki 38 · Visoms lytims · Atnaujinta 2026-10-01 · NCT06131801A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Renkami dalyviai1 fazė
Amžius nuo 12 iki 78 · Visoms lytims · Atnaujinta 2026-09-29 · NCT03802695A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-29 · NCT06763341Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Renkami dalyviai2 fazė
Amžius nuo 18 iki 59 · Visoms lytims · Atnaujinta 2026-09-28 · NCT05554393A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT06852222MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT05564390Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT03629171A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT06548230Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Renkami dalyviai3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07211958Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-24 · NCT03874052Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Renkami dalyviaiAnkstyvoji 1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-24 · NCT06398457Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-24 · NCT03661307Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-24 · NCT06871410A Phase I-II Study Investigating the All-Oral Combination of the Menin Inhibitor SNDX-5613 With Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE)
Renkami dalyviai1/2 fazėLaukiami sveiki savanoriai
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT05360160A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
Renkami dalyviai1 fazė
Iki 21 metų · Visoms lytims · Atnaujinta 2026-09-23 · NCT07012044Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT06317649A Study of CRD3874-SI in People With Leukemia
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT07661095Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.